1,6- epi-Cyclophellitol Cyclosulfamidate Is a Bona Fide Lysosomal α-Glucosidase Stabilizer for the Treatment of Pompe Disease

Kok, Ken, Kuo, Chi Lin, Katzy, Rebecca E. et al. (10 more authors) (2022) 1,6- epi-Cyclophellitol Cyclosulfamidate Is a Bona Fide Lysosomal α-Glucosidase Stabilizer for the Treatment of Pompe Disease. Journal of the American Chemical Society. 14819–14827. ISSN 1520-5126

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

Funding Information: We thank The Netherlands Organization for Scientific Research (NWO-CW, ChemThem grant to J.M.F.G.A. and H.S.O.), the European Research Council (ERC-2011-AdG-290836 “Chembiosphing” to H.S.O., ERC-2012-AdG-322942 “Glycopoise” to G.J.D. and ERC-2020-SyG-951231 “Carbocentre” to H.S.O. and G.J.D.), Sanofi Genzyme (research grant to J.M.F.G.A. and H.S.O. for financial support, postdoctoral contract to M.A. and Myozyme supply). G.J.D. is supported by the Royal Society though the Ken Murray Research Professorship. We kindly thank Giancarlo Parenti, Federico II University Naples, for providing Myozyme samples for structural studies. We thank Andrea Dardis and the Biobank from Patients Affected by ALS Neuromuscular and Lysosomal Diseases (University Hospital of Udine, Italy) for providing us with plasma samples from Pompe patients. We thank Synchrotron Soleil for beam time allocation and the beam line staff for assistance with data collection. This work was also supported in part by the CNRS and the French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INSB-05-01. Funding Information: We thank The Netherlands Organization for Scientific Research (NWO-CW, ChemThem grant to J.M.F.G.A. and H.S.O.), the European Research Council (ERC-2011-AdG-290836 “Chembiosphing” to H.S.O., ERC-2012-AdG-322942 “Glycopoise” to G.J.D., and ERC-2020-SyG-951231 “Carbocentre” to H.S.O. and G.J.D.), Sanofi Genzyme (research grant to J.M.F.G.A. and H.S.O. for financial support, postdoctoral contract to M.A. and Myozyme supply). G.J.D. is supported by the Royal Society though the Ken Murray Research Professorship. We kindly thank Giancarlo Parenti, Federico II University, Naples, for providing Myozyme samples for structural studies. We thank Andrea Dardis and the Biobank from Patients Affected by ALS, Neuromuscular and Lysosomal Diseases (University Hospital of Udine, Italy) for providing us with plasma samples from Pompe patients. We thank Synchrotron Soleil for beam time allocation and the beam line staff for assistance with data collection. This work was also supported in part by the CNRS and the French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INSB-05-01. Publisher Copyright: © 2022 The Authors. Published by American Chemical Society.

Dates:
  • Published: 2 August 2022
Institution: The University of York
Academic Units: The University of York > Faculty of Sciences (York) > Chemistry (York)
Funding Information:
Funder
Grant number
EUROPEAN COMMISSION
951231
BBSRC (BIOTECHNOLOGY AND BIOLOGICAL SCIENCES RESEARCH COUNCIL)
BB/R001162/1
THE ROYAL SOCIETY
RSRP\R\210004
Depositing User: Pure (York)
Date Deposited: 09 Sep 2022 11:00
Last Modified: 12 Jan 2025 00:08
Published Version: https://doi.org/10.1021/jacs.2c05666
Status: Published
Refereed: Yes
Identification Number: 10.1021/jacs.2c05666
Related URLs:
Open Archives Initiative ID (OAI ID):

Download

Filename: jacs.2c05666.pdf

Description: jacs.2c05666

Licence: CC-BY 2.5

Export

Statistics